Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $8.3 million.

  • Tandem Diabetes Care's Cash from Operations fell 6914.0% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.8 million, marking a year-over-year decrease of 23974.89%. This contributed to the annual value of $24.2 million for FY2024, which is 17615.53% up from last year.
  • Per Tandem Diabetes Care's latest filing, its Cash from Operations stood at $8.3 million for Q3 2025, which was down 6914.0% from -$9.5 million recorded in Q2 2025.
  • Tandem Diabetes Care's Cash from Operations' 5-year high stood at $34.1 million during Q3 2021, with a 5-year trough of -$18.3 million in Q1 2023.
  • In the last 5 years, Tandem Diabetes Care's Cash from Operations had a median value of $6.9 million in 2022 and averaged $7.1 million.
  • In the last 5 years, Tandem Diabetes Care's Cash from Operations tumbled by 23279.71% in 2023 and then surged by 4858909.09% in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Cash from Operations stood at $19.6 million in 2021, then tumbled by 70.36% to $5.8 million in 2022, then tumbled by 223.99% to -$7.2 million in 2023, then soared by 248.52% to $10.7 million in 2024, then decreased by 22.89% to $8.3 million in 2025.
  • Its last three reported values are $8.3 million in Q3 2025, -$9.5 million for Q2 2025, and -$18.3 million during Q1 2025.